BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6165784)

  • 1. Viral-induced leukocyte interferon in vesicle fluid from lesions of recurrent herpes labialis.
    Overall JC; Spruance SL; Green JA
    J Infect Dis; 1981 Apr; 143(4):543-7. PubMed ID: 6165784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous and induced interferon production by peripheral blood mononuclear leukocytes from humans with herpes labialis.
    Green JA; Weiss PN; Spruance SL
    J Immunol; 1983 Dec; 131(6):2827-9. PubMed ID: 6196402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer.
    Spruance SL; Green JA; Chiu G; Yeh TJ; Wenerstrom G; Overall JC
    Infect Immun; 1982 Jun; 36(3):907-10. PubMed ID: 6178690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent herpes simplex labialis: viral replication and clinical course.
    Rytel MW; Niebojewski RA; Aguilar-Torres FG; Russell TJ
    Am J Med Sci; 1978; 276(3):319-23. PubMed ID: 217269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis.
    Daniels CA; LeGoff SG
    Lancet; 1975 Sep; 2(7934):524-8. PubMed ID: 51344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy.
    Spruance SL; Overall JC; Kern ER; Krueger GG; Pliam V; Miller W
    N Engl J Med; 1977 Jul; 297(2):69-75. PubMed ID: 194157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis.
    Pica F; Volpi A; Gaziano R; Garaci E
    Antivir Ther; 2010; 15(5):737-43. PubMed ID: 20710055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gamma Interferon production appears to predict time of recurrence of herpes labialis.
    Cunningham AL; Merigan TC
    J Immunol; 1983 May; 130(5):2397-400. PubMed ID: 6403619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study.
    Bernstein DI; Spruance SL; Arora SS; Schroeder JL; Meng TC
    Clin Infect Dis; 2005 Sep; 41(6):808-14. PubMed ID: 16107978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of herpes simplex labialis: experimental induction of lesions with UV light.
    Spruance SL
    J Clin Microbiol; 1985 Sep; 22(3):366-8. PubMed ID: 2995436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of recurrent herpes simplex labialis. IV. Maturation of lesions within 8 hours after onset and implications for antiviral treatment.
    Spruance SL; Wenerstrom G
    Oral Surg Oral Med Oral Pathol; 1984 Dec; 58(6):667-71. PubMed ID: 6095159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta interferon produced by keratinocytes in human cutaneous infection with herpes simplex virus.
    Torseth JW; Nickoloff BJ; Basham TY; Merigan TC
    J Infect Dis; 1987 Apr; 155(4):641-8. PubMed ID: 2434580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root.
    Pazin GJ; Armstrong JA; Lam MT; Tarr GC; Jannetta PJ; Ho M
    N Engl J Med; 1979 Aug; 301(5):225-30. PubMed ID: 221812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic cross-reaction between the alpha types of human and mouse interferon.
    Kawade Y; Watanabe Y; Yamamoto Y; Fujisawa J; Dalton BJ; Paucker K
    Antiviral Res; 1981 Sep; 1(3):167-78. PubMed ID: 6175276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of recurrent herpes simplex labialis with levamisole.
    Spruance SL; Krueger GG; MacCalman J; Overall JC; Klauber MR
    Antimicrob Agents Chemother; 1979 May; 15(5):662-5. PubMed ID: 525982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrent herpes labialis and secondary bacterial infection. A study among the employees at the Ulleval hospital].
    Laerum E; Størvold G; Svele J; Volker L; Thune P; Bruun JN
    Tidsskr Nor Laegeforen; 1991 Apr; 111(11):1366-8. PubMed ID: 2042157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
    Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
    JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of herpes simplex labialis. I. Replication of herpes simplex virus in cultures of epidermal cells from subjects with frequent recurrences.
    Spruance SL; Chow FS
    J Infect Dis; 1980 Nov; 142(5):671-5. PubMed ID: 6257796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The virological diagnosis of recurrent labial herpes].
    Durov VM
    Stomatologiia (Mosk); 1991; (6):22-3. PubMed ID: 1666465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient recognition of recrudescent herpes labialis: a clinical and virological assessment.
    Lamey PJ; Biagioni PA
    J Dent; 1996 Sep; 24(5):325-7. PubMed ID: 8916645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.